214 related articles for article (PubMed ID: 33220356)
1. Updating the International IgA Nephropathy Prediction Tool for use in children.
Barbour SJ; Coppo R; Er L; Russo ML; Liu ZH; Ding J; Katafuchi R; Yoshikawa N; Xu H; Kagami S; Yuzawa Y; Emma F; Cambier A; Peruzzi L; Wyatt RJ; Cattran DC;
Kidney Int; 2021 Jun; 99(6):1439-1450. PubMed ID: 33220356
[TBL] [Abstract][Full Text] [Related]
2. Application of the International IgA Nephropathy Prediction Tool one or two years post-biopsy.
Barbour SJ; Coppo R; Zhang H; Liu ZH; Suzuki Y; Matsuzaki K; Er L; Reich HN; Barratt J; Cattran DC;
Kidney Int; 2022 Jul; 102(1):160-172. PubMed ID: 35490842
[TBL] [Abstract][Full Text] [Related]
3. Evaluating a New International Risk-Prediction Tool in IgA Nephropathy.
Barbour SJ; Coppo R; Zhang H; Liu ZH; Suzuki Y; Matsuzaki K; Katafuchi R; Er L; Espino-Hernandez G; Kim SJ; Reich HN; Feehally J; Cattran DC;
JAMA Intern Med; 2019 Jul; 179(7):942-952. PubMed ID: 30980653
[TBL] [Abstract][Full Text] [Related]
4. External validation of the pediatric International IgA Nephropathy Prediction Tool in a central China cohort.
Ying D; Lu M; Zhi Y; Shi P; Cao L; Wang Q; Zhang Y; Zhang J
Clin Exp Nephrol; 2024 Jan; 28(1):59-66. PubMed ID: 37713045
[TBL] [Abstract][Full Text] [Related]
5. Is it possible to predict the evolution of IgAN? Validation of the IgA nephropathy progression calculator and its relationship with MEST-C score in our population.
Martín-Penagos L; Benito A; Oviedo MV; López Del Moral Cuesta C; Martín López J; Gómez Román J; López-Mejías R; Fernandez-Fresnedo G; Ruíz San Millán JC; Rodrigo Calabia E
Nefrologia (Engl Ed); 2019; 39(5):523-530. PubMed ID: 30902505
[TBL] [Abstract][Full Text] [Related]
6. Kidney Failure Risk Prediction Equations in IgA Nephropathy: A Multicenter Risk Assessment Study in Chinese Patients.
Xie J; Lv J; Wang W; Li G; Liu Z; Chen H; Xu F; Sun J; Ouyang Y; Zhang X; Yang M; Shi M; Zhang W; Ren H; Kiryluk K; Zhang H; Chen N
Am J Kidney Dis; 2018 Sep; 72(3):371-380. PubMed ID: 29555434
[TBL] [Abstract][Full Text] [Related]
7. Validation of two IgA nephropathy risk-prediction tools using a cohort with a long follow-up.
Haaskjold YL; Lura NG; Bjørneklett R; Bostad L; Bostad LS; Knoop T
Nephrol Dial Transplant; 2023 May; 38(5):1183-1191. PubMed ID: 35904322
[TBL] [Abstract][Full Text] [Related]
8. External Validation of the International Prognosis Prediction Model of IgA Nephropathy.
Hu L; Fang Y; Huang J; Liu J; Xu L; He W
Ren Fail; 2024 Dec; 46(1):2313174. PubMed ID: 38345077
[TBL] [Abstract][Full Text] [Related]
9. Validation of the international IgA nephropathy prediction tool in a French cohort beyond 10 years after diagnosis.
Bon G; Jullien P; Masson I; Sauron C; Dinic M; Claisse G; Pelaez A; Thibaudin D; Mohey H; Alamartine E; Mariat C; Maillard N
Nephrol Dial Transplant; 2023 Sep; 38(10):2257-2265. PubMed ID: 37316441
[TBL] [Abstract][Full Text] [Related]
10. External Validation of the International IgA Nephropathy Prediction Tool in Older Adult Patients.
Zhang Q; Zhang Q; Duan Z; Chen P; Chen JJ; Li MX; Zhang JJ; Huo YH; Zhang WX; Yang C; Zhang Y; Chen X; Cai G
Clin Interv Aging; 2024; 19():911-922. PubMed ID: 38799377
[TBL] [Abstract][Full Text] [Related]
11. External Validation of the International IgA Nephropathy Prediction Tool.
Zhang J; Huang B; Liu Z; Wang X; Xie M; Guo R; Wang Y; Yu D; Wang P; Zhu Y; Ren J
Clin J Am Soc Nephrol; 2020 Aug; 15(8):1112-1120. PubMed ID: 32616496
[TBL] [Abstract][Full Text] [Related]
12. The MEST score provides earlier risk prediction in lgA nephropathy.
Barbour SJ; Espino-Hernandez G; Reich HN; Coppo R; Roberts IS; Feehally J; Herzenberg AM; Cattran DC; ;
Kidney Int; 2016 Jan; 89(1):167-75. PubMed ID: 26759049
[TBL] [Abstract][Full Text] [Related]
13. Mesangial C4d deposition may predict progression of kidney disease in pediatric patients with IgA nephropathy.
Fabiano RCG; de Almeida Araújo S; Bambirra EA; Oliveira EA; Simões E Silva AC; Pinheiro SVB
Pediatr Nephrol; 2017 Jul; 32(7):1211-1220. PubMed ID: 28233100
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort.
Coppo R; Lofaro D; Camilla RR; Bellur S; Cattran D; Cook HT; Roberts IS; Peruzzi L; Amore A; Emma F; Fuiano L; Berg U; Topaloglu R; Bilginer Y; Gesualdo L; Polci R; Mizerska-Wasiak M; Caliskan Y; Lundberg S; Cancarini G; Geddes C; Wetzels J; Wiecek A; Durlik M; Cusinato S; Rollino C; Maggio M; Praga M; K Smerud H; Tesar V; Maixnerova D; Barratt J; Papalia T; Bonofiglio R; Mazzucco G; Giannakakis C; Soderberg M; Orhan D; Di Palma AM; Maldyk J; Ozluk Y; Sudelin B; Tardanico R; Kipgen D; Steenbergen E; Karkoszka H; Perkowska-Ptasinska A; Ferrario F; Gutierrez E; Honsova E
Pediatr Nephrol; 2017 Jan; 32(1):139-150. PubMed ID: 27557557
[TBL] [Abstract][Full Text] [Related]
15. Patient classification and outcome prediction in IgA nephropathy.
Diciolla M; Binetti G; Di Noia T; Pesce F; Schena FP; Vågane AM; Bjørneklett R; Suzuki H; Tomino Y; Naso D
Comput Biol Med; 2015 Nov; 66():278-86. PubMed ID: 26453758
[TBL] [Abstract][Full Text] [Related]
16. Renal Interstitial Inflammation Predicts Nephropathy Progression in IgA Nephropathy: A Two-Center Cohort Study.
Zhu B; Liu WH; Lin Y; Li Q; Yu DR; Jiang F; Tang XL; Du YY; Yin JZ; Li XF; Zhong YZ; Wang WR; Sun Y; Zhang MJ; Gao YC; Yuan CY; Zhu CF; Cheng XX
Am J Nephrol; 2022; 53(6):455-469. PubMed ID: 35576899
[TBL] [Abstract][Full Text] [Related]
17. A validation study of crescents in predicting ESRD in patients with IgA nephropathy.
Zhang X; Shi S; Ouyang Y; Yang M; Shi M; Pan X; Lv J; Wang Z; Ren H; Shen P; Wang W; Zhang H; Xie J; Chen N
J Transl Med; 2018 May; 16(1):115. PubMed ID: 29724226
[TBL] [Abstract][Full Text] [Related]
18. Serum Phosphorus Might Be a Predictor of Kidney Disease Progression in IgA Nephropathy.
Li H; Lu W; Xie X; Wang Y; Dang X; Sun J; Jiang H
Kidney Blood Press Res; 2024; 49(1):20-26. PubMed ID: 38048756
[TBL] [Abstract][Full Text] [Related]
19. Urinary Matrix Metalloproteinase 7 and Prediction of IgA Nephropathy Progression.
Yang X; Ou J; Zhang H; Xu X; Zhu L; Li Q; Li J; Xie D; Sun J; Zha Y; Li Y; Tian J; Liu Y; Hou FF
Am J Kidney Dis; 2020 Mar; 75(3):384-393. PubMed ID: 31606236
[TBL] [Abstract][Full Text] [Related]
20. Treatment effects of Chinese medicine (Yi-Qi-Qing-Jie herbal compound) combined with immunosuppression therapies in IgA nephropathy patients with high-risk of end-stage renal disease (TCM-WINE): study protocol for a randomized controlled trial.
Li S; Li JP
Trials; 2020 Jan; 21(1):31. PubMed ID: 31907076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
